Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection (Q43517221)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection
scientific article

    Statements

    Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection (English)
    M van der Valk
    E H Gisolf
    A Japour
    G J Weverling
    S A Danner
    Prometheus study group
    847-855

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit